EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NRAS Q61R Expression in Lymphatic Endothelial Cells Causes Enlarged Vessels, Hemorrhagic Chylous Effusions, and High Mortality in a Mouse Model of Kaposiform Lymphangiomatosis

C Griffin McDaniel, Patricia Pastura, Joshua P Scallan, Timothy D Le Cras

Pediatric Blood & Cancer · 2026-07 · 73 (7)

DOI: 10.1002/1545-5017.70339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 16.04.2026. Verfasst von C Griffin McDaniel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medici…. Hauptthemen laut MEDLINE: Disease Models, Animal, Lymphatic Vessels, Endothelial Cells, Hemangioendothelioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kaposiform lymphangiomatosis (KLA) is an aggressive complex lymphatic anomaly. Patients exhibit malformed lymphatic vessels and often develop hemorrhagic effusions and elevated angiopoietin‐2 (Ang‐2) levels. A somatic NRAS p.Q61R (NRAS Q61R ) mutation has been associated with KLA. Existing preclinical models do not recapitulate the thoracic effusions that drive morbidity and mortality in patients. The goal of this study was to develop a genetic mouse model that more closely mimics the clinical phenotype of KLA. Procedure A tamoxifen‐inducible Cre‐loxP system was used to conditionally express NRAS Q61R in lymphatic endothelial cells in postnatal mice. Prox1‐CreERT2 mice were mated to Lox‐STOP‐Lox‐NRAS Q61R mice. Tamoxifen (100 or 75 µg) was administered to litters on postnatal days (P) 1–3 to induce Cre‐mediated recombination and NRAS Q61R expression. Survival, effusion incidence, and plasma Ang‐2 levels were assessed at 3 weeks. Recombination efficiency and lymphatic vessel structure in the lungs and whole‐mounts of the diaphragm and ear were determined.

Results

NRAS Q61R mice treated with 100 µg tamoxifen P1–P3 died within 5 weeks. NRAS Q61R mice treated with 75 µg tamoxifen P1–P3 had increased mortality, severe hemorrhagic and chylous effusions, and approximately three‐fold higher angiopoietin‐2 levels. NRAS Q61R recombination was 93% in the pulmonary lymphatics, which were enlarged and abnormal. Lymphatic vessel diameters were increased in the diaphragm (193%) and ears (152%).

Conclusions

NRAS Q61R mutant mice closely resemble KLA patients with high mortality, hemorrhagic chylothorax, elevated Ang‐2 levels, and enlarged lymphatic vessels. Future studies can utilize this model to elucidate the mechanisms underlying KLA pathogenesis and test novel therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalLymphatic VesselsEndothelial CellsHemangioendotheliomaKasabach-Merritt SyndromeChylothoraxGTP PhosphohydrolasesMembrane ProteinsHemorrhageMonomeric GTP-Binding ProteinsAnimalsMiceFemaleAngiopoietin-2Sarcoma, Kaposi

Stichwörter der Autor:innen

RASopathylymphatic malformationpreclinical modelvascular anomalies

Substanzen

Nras protein, mouseGTP PhosphohydrolasesMembrane ProteinsAngiopoietin-2Monomeric GTP-Binding Proteins

Autor:innen und Institutionen

  • Division of Pulmonary Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Molecular Pharmacology and Physiology, Morsani School of Medicine, University of South Florida, Tampa, Florida, USA.

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

McDaniel, C. G., Pastura, P., Scallan, J. P., & Le Cras, T. D. (2026). NRAS Q61R Expression in Lymphatic Endothelial Cells Causes Enlarged Vessels, Hemorrhagic Chylous Effusions, and High Mortality in a Mouse Model of Kaposiform Lymphangiomatosis. Pediatric Blood & Cancer, 73(7). https://doi.org/10.1002/1545-5017.70339

Vancouver

McDaniel CG, Pastura P, Scallan JP, Le Cras TD. NRAS Q61R Expression in Lymphatic Endothelial Cells Causes Enlarged Vessels, Hemorrhagic Chylous Effusions, and High Mortality in a Mouse Model of Kaposiform Lymphangiomatosis. Pediatric Blood & Cancer. 2026;73(7). doi:10.1002/1545-5017.70339

BibTeX
@article{McDaniel2026,
  author = {McDaniel, C Griffin and Pastura, Patricia and Scallan, Joshua P and Le Cras, Timothy D},
  title = {NRAS Q61R Expression in Lymphatic Endothelial Cells Causes Enlarged Vessels, Hemorrhagic Chylous Effusions, and High Mortality in a Mouse Model of Kaposiform Lymphangiomatosis},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {7},
  doi = {10.1002/1545-5017.70339}
}
Kostenlos starten →